Diferencia entre revisiones de «HIV post-exposure prophylaxis»
Sin resumen de edición |
|||
| Línea 18: | Línea 18: | ||
*Common side-effects = constitutional, gastrointestinal | *Common side-effects = constitutional, gastrointestinal | ||
CDC | ===Specific Regimens (CDC)=== | ||
#Basic | #Basic | ||
##Exposures for which there is a recognized transmission risk | ##Exposures for which there is a recognized transmission risk | ||
Revisión del 04:40 28 mar 2011
Workup
- Td
- Hepatitis B PEP for non-vaccinated
- Hepatitis B immunoglobulin and/or vaccine
- Source labs
- Rapid HIV, hep pannel, RPR?
- Exposed labs
- Rapid HIV, hep pannel, RPR?
- Consider HIV PEP
- CBC, C7, LFTs, Icon if considering HIV PEP
^Currently no PEP for Hep C
HIV PEP
- ~79% transmission reduction
- Initiate ASAP (goal = 1-2 hours)
- >36 hours: normally deferred, unless particularly high risk
- Common side-effects = constitutional, gastrointestinal
Specific Regimens (CDC)
- Basic
- Exposures for which there is a recognized transmission risk
- 4 week, 2 drug regimen (normally zidovudine and lamivudine)
- Expanded
- High risk exposures
- Basic regimen + protease inhibitor (e.g. indinavir or nelfinavir)
HIGH RISK
Source
- Symptomatic HIV/AIDS
- Acute seroconversion
- High viral load
Exposure
- Deep injuries
- Visible blood on device
- Injuries sustained placing a catheter in a vein/artery
Source
8/07 DONALDSON
